Transgene at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Transgene takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program centres on virus-based cancer vaccines and new immunotherapy science for patients with few treatment options. It presents TG4050, a virus-based vaccine personalized to each patient's tumor mutations, given after standard treatment in head and neck cancer.

OrganizationFestival of Biologics 2026 Attendance
transgene.fr
Biotech
Develops viral vector-based immunotherapies, including individualized neoantigen cancer vaccines and oncolytic viruses.
Panel
Tue Oct 13
12:20
PANEL DISCUSSION: The Next Frontier: Delivering Next-Gen Science for Patients with High Unmet Need
Immunotherapy Keynotes · with Novartis, Memorial Sloan Kettering Cancer Center, STAb Therapeutics +1 more
Talk
Tue Oct 13
14:30
TG4050, a viral-based individualized neoantigen vaccine as adjuvant treatment in head and neck cancer
Therapeutic Vaccine Development

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Transgene

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction